trending Market Intelligence /marketintelligence/en/news-insights/trending/29DBXyhIlAguTRxifECVTg2 content esgSubNav
In This List

Immunicum nominates board chairman

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Immunicum nominates board chairman

Immunicum AB plans to appoint Michael Oredsson as its chairman, pending shareholder approval at its upcoming annual meeting.

The decision was made after Agneta Edberg, the company's current chairman, said she will not stand for re-election.

Oredsson served as CEO of Swedish biotechnology company BioInvent International AB until the end of 2017.

Gothenburg, Sweden-based Immunicum develops therapeutic cancer vaccines.